Because there is a dwindling number of states that haven’t legalized medical and/or recreational marijuana, it is easy to be fooled into believing opportunities to get a cannabis business license would likewise be shrinking.
Opportunities abound, however.
While 2024 brought its share of volatility, regulatory uncertainty and market pressures for the cannabis industry, this year offers potential opportunities alongside continued challenges.
Instead of putting the finishing touches on their businesses in anticipation of Minnesota’s adult-use market launch early this year, marijuana license applicants instead face delays and uncertainty.
The executives behind New York cannabis infused products company Jaunty learned the hard way that even the best-laid plans can go awry because of the unexpected.
Companies and scientific institutions could sell adult-use products in Germany under new legislation that allows these groups to seek licenses for cannabis pilot programs.
Hawaii’s medical cannabis market reached a milestone with the opening of the state’s 25th dispensary.
Zachary Eisenberg spoke about pesticides and potency manipulation, what can be done to solve these problems and backlash for being a whistleblower.
Attendees who want to leave the MJBizCon with leads and fruitful relationships should come with a game plan but also be prepared to be flexible.
Canadian cannabis company Canopy Growth Corp. appointed current board member Luc Mongeau to serve as the company’s next CEO.
CEO Jaap Erkelens said Bedrocan – one of the oldest medical marijuana companies in the world – received a new license from Health Canada.
High Tide, a Calgary, Alberta-based cannabis retail chain, drew the final 5 million Canadian dollars ($3.6 million) of a CA$15 million debt facility.
A group of seven recreational cannabis stores in Washington, D.C., is suing several city officials to stop enforcement actions against their businesses.
